These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2570422)

  • 21. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.
    Ye WW; Mason BB; Chengalvala M; Cheng SM; Zandle G; Lubeck MD; Lee SG; Mizutani S; Davis AR; Hung PP
    Arch Virol; 1991; 118(1-2):11-27. PubMed ID: 1828660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and immunological analysis of recombinant hepatitis B vaccine.
    Emini EA; Ellis RW; Miller WJ; McAleer WJ; Scolnick EM; Gerety RJ
    J Infect; 1986 Jul; 13 Suppl A():3-9. PubMed ID: 2427590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.
    Kamili S; Sozzi V; Thompson G; Campbell K; Walker CM; Locarnini S; Krawczynski K
    Hepatology; 2009 May; 49(5):1483-91. PubMed ID: 19274751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein.
    Emini EA; Larson V; Eichberg J; Conard P; Garsky VM; Lee DR; Ellis RW; Miller WJ; Anderson CA; Gerety RJ
    J Med Virol; 1989 May; 28(1):7-12. PubMed ID: 2723618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.
    del Valle JR; Devaux P; Hodge G; Wegner NJ; McChesney MB; Cattaneo R
    J Virol; 2007 Oct; 81(19):10597-605. PubMed ID: 17634218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B vaccine produced in yeast.
    Bitter GA; Egan KM; Burnette WN; Samal B; Fieschko JC; Peterson DL; Downing MR; Wypych J; Langley KE
    J Med Virol; 1988 Jun; 25(2):123-40. PubMed ID: 3292698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants.
    Kamili S
    Antivir Ther; 2010; 15(3 Pt B):477-85. PubMed ID: 20516568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
    Ho JK; Jeevan-Raj B; Netter HJ
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31973017
    [No Abstract]   [Full Text] [Related]  

  • 34. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
    Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
    J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.